REGENERON PHARMACEUTICALS, INC. Construction in Progress, Gross
REGENERON PHARMACEUTICALS, INC. (REGN) had Construction in Progress, Gross of $408.86 million as of 2017-12-31, per its 10-K filed 2018-02-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2018-02-08
- 2017-12-31: Construction in Progress, Gross $408.86M.
- 2016-12-31: Construction in Progress, Gross $318.93M.
- 2015-12-31: Construction in Progress, Gross $579.83M.
- 2014-12-31: Construction in Progress, Gross $472.23M.
| Period end | Construction in Progress, Gross |
|---|---|
| 2017-12-31 | $408.86M 10-K · filed 2018-02-08 |
| 2016-12-31 | $318.93M 10-K · filed 2018-02-08 |
| 2015-12-31 | $579.83M 10-K · filed 2017-02-09 |
| 2014-12-31 | $472.23M 10-K · filed 2016-02-11 |
| 2013-12-31 | $142.37M 10-K · filed 2015-02-12 |
| 2013-09-30 | $7.70M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $4.70M 10-Q · filed 2013-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |